Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor (pasireotide) injection for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.
URL: http://www.news-medical.net/news/20121214/FDA-approves-Novartis-Signifor-injection-for-treatment-of-Cushings-disease.aspx
No comments:
Post a Comment